Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2.
Zhao H, To KKW, Lam H, Zhou X, Chan JF, Peng Z, Lee ACY, Cai J, Chan WM, Ip JD, Chan CC, Yeung ML, Zhang AJ, Chu AWH, Jiang S, Yuen KY.
Zhao H, et al.
Nat Commun. 2021 Mar 9;12(1):1517. doi: 10.1038/s41467-021-21825-w.
Nat Commun. 2021.
PMID: 33750821
Free PMC article.